Background:

To evaluate and compare the treatment outcomes of using topical steroids combined with antibiotics versus growth factor concentrate in type 1 tympanoplasty for chronic otitis media (mucosal type) cases.

Materials and Methods:

The study comprised patients with chronic otitis media mucosal type, who underwent type 1 tympanoplasty. Sixty six patients were randomly divided into 3 groups, each consisting of 33 patients. In Group A, topical steroids and antibiotics were used during the procedure, while in Group B, a growth factor concentrate was used. The outcomes were assessed through postoperative otoendoscopy and air bone gap at the end of the 1st and 3rd months.

Results:

In this study, Group A (patients who underwent type 1 tympanoplasty with topical steroids and antibiotics) had a 12.1% rate of residual perforation and an 18.2% rate of reperforation after 3 months. In contrast, Group B (patients treated with growth factor concentrate) had significantly lower rates of both residual perforation (3%) and reperforation (3%). While the postoperative air-bone gap at the end of the 3rd month improved in Group B (13.58 ± 3.21 dB) compared to Group A (15.45 ± 5.11 dB), the difference was not statistically significant.

Conclusion:

Growth factor concentrate has shown better graft uptake than topical antibiotics and steroids, making it a promising treatment option for augmenting tympanic membrane repair. Its biocompatibility leads to more consistent outcomes, improving patient satisfaction, and supporting broader use in otologic surgeries.

Search results

“Impact of Growth Factor Concentrate Versus Topical Steriods With Antibiotics in Type 1 Tympanoplasty”